Darqube is a comprehensive platform for smarter investing. The company aims to equip finance enthusiasts, novice traders, and professionals with financial technology instruments, trading analytics, and algorithmic trading tools to hasten investment decisions. The company has multiple financial products on its platform like forex, mutual funds, cryptocurrency, and bonds. In 2019, the company launched 'Terminal', a comprehensive trading analytics platform. The year 2020 saw the company launch 'TradeLab Beta', an algorithmic trading platform, and 'Messenger', a messaging platform tailored to the needs of finance enthusiasts. Darqube has 5000 monthly active users and 75,000+ community followers. The company has also been featured in prominent publications like Business Insider, Yahoo Finance, and Marketwatch. The company will use 40% of the investment towards growth and user acquisition, 25% for product improvement, 25% for team expansion, and 10% as operating costs.
days to go:
Expired
investment:
£461,811
Equipsme is on a mission to democratise health insurance by making it affordable for businesses of all sizes. The company cites data arguing that there has been a 53% increase in National Health Service (NHS) treatment waiting lists since 2012 due to the low reach of health insurance by conventional insurance companies. It aims to change this scenario. Equipsme offers flexible fixed-price packages to companies wherein employees are allowed to upgrade and add family members to their plan as per their pleasure. Members can also speak to a General Physician (GP) 24/7, and, if necessary, be referred to a consultant for diagnosis and treatment through the company's proprietary app. The company was felicitated with the 'Best New Product' award by Cover Magazine Excellence Awards 2019. The company will use the investment to enhance its user experience, ensure its technology remains market-leading, and scale its marketing and customer service capability.
days to go:
Expired
investment:
£286,096
Kuuka is an on-demand last-mile logistics delivery service using Artificial Intelligence (AI) to provide cost-effective same-day last-mile deliveries allowing customers to schedule and monitor their requests in real-time. The company aims to achieve this by continuously adding parcel collections and deliveries to a driver’s route throughout the day. Kuuka believes that this approach will increase fleet utilisation and reduce the cost of delivery leading to a faster delivery process. It aims to be a contender in the estimated £5,447,763 last-mile delivery market. Kuuka asserts that it provides services such as moving goods on-demand, property and office removals, and courier and parcel deliveries, to name a few. Kuuka will use the investment to establish key channel partnerships and launch its final app. Its exit strategy is to trade sell to other companies that would want to acquire them.
days to go:
Expired
investment:
£5,450
Rebel Energy (RE) is an energy supplier on a mission to address inequality and provide everyone with easy access to clean and affordable energy, to eventually eliminate fuel poverty. RE claims that fuel poverty led to 16,500+ cold-related deaths in the UK in 2018. RE argues that as the UK home electricity market enters a phase of growth in a post-COVID world, it will be focused on offering reliable customer service and develop strategies that help people who are struggling with their electricity bills. The company has applied for a B Corporation accreditation. RE asserts that its customer support systems are automated and can handle multiple queries simultaneously. It plans to offer a weekly direct debit payment option. RE will use the investment to grow its business across different verticals.
days to go:
Expired
investment:
£503,810
Grow is a British biopharmaceutical company on a mission to unlock the potential of cannabis medicines for patients globally. It claims that it is one of the largest importers of cannabis medicines in the UK and Ireland since its founding in 2017. The company has raised over £9.5 million through several fundraising rounds to allow expansion of operations, supplied medicines to more than 1,200 patients a month as of June 2021, and earned £2.35 million in revenue as of July 20, 2021. The company has also launched its patient app, Calyx, to help patients track their medications and health indicators and signed long term partnerships with some of the world’s leading cannabis companies, including Aurora, Tilray and Columbia Care. The company argues that it has also pioneered the ‘Open Cannabis’ campaign to improve education on cannabis medicines and the means to access them in the UK. It states it will use 40% of the investment on capital expenditure, 30% on hiring new personnel, and 30% as working capital.
days to go:
Expired
investment:
£3,566,133
End-to-end platform that enables content owners to profitably deliver video content direct-2-user in a complex multi-device world.
days to go:
Expired
investment:
£510,000
Vizaviz have re-invented social publishing by enabling content creators and marketing managers to map out strategies for major social and publishing platforms and put these strategies into work from one interface. Founder Rodney Lam spent years as a COO in the music industry and found managing all social activities of artists challenging and time consuming so built a tool to offer an easy solution.
days to go:
Expired
investment:
£58,931
Plum helps users save money, invest and not overpay bills using an AI-enabled financial butler. Plum links to your bank account and using a smart algorithm driven by AI identifies opportunities to save small amounts of money and ensures you are not overpaying your bills by suggesting cheaper alternatives.
days to go:
Expired
investment:
£923,255
Avida Global (AG) is a Business-to-Business (B2B) producer of high-quality medicinal cannabis oils and derivatives for the global medical, well-being and cosmeceutical markets. The company has a cultivation and processing facility in North-East Colombia. It asserts that the therapeutic properties of the cannabis plant has driven 53 countries to legalise its use, with more to follow. AG seeks to capture this demand and become a contender in the medicinal cannabis market that is expected to soar from $33.1 billion to $84.0 billion by 2028. The company has received regulatory approvals for initial non-psychoactive cannabis cultivation, manufacturing, and export licences in 2019. It is working on a partnership with a medicinal cannabis prescriber through doctors and clinics for the supply of medicinal cannabis strains in the UK. The company will use 40% of the investment to drive revenue growth, 25% as capital expenses, and 35% as additional operating expenses.
days to go:
Expired
investment:
£1,646,249
Channels such as eBay and Amazon present a tremendous opportunity for SME’s to sell their products benefiting their businesses. This, however, also introduces a range of new challenges e.g. how to keep stock up to date on all channels. Developing proprietary systems to manage these is complex and expensive. ESeller Express offers a cost effective, instantly available, cloud based system which arms SME’s with just the tools they need to manage their businesses efficiently.
days to go:
Expired
investment:
£23,000
